Log in to save to my catalogue

Co-expression of CD147/EMMPRIN with monocarboxylate transporters and multiple drug resistance protei...

Co-expression of CD147/EMMPRIN with monocarboxylate transporters and multiple drug resistance protei...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_762470455

Co-expression of CD147/EMMPRIN with monocarboxylate transporters and multiple drug resistance proteins is associated with epithelial ovarian cancer progression

About this item

Full title

Co-expression of CD147/EMMPRIN with monocarboxylate transporters and multiple drug resistance proteins is associated with epithelial ovarian cancer progression

Publisher

Dordrecht: Dordrecht : Springer Netherlands

Journal title

Clinical & experimental metastasis, 2010-12, Vol.27 (8), p.557-569

Language

English

Formats

Publication information

Publisher

Dordrecht: Dordrecht : Springer Netherlands

More information

Scope and Contents

Contents

Cancer metastasis and anti-cancer drug resistance are the major reason for the failure of clinical cancer treatment. We evaluated CD147, monocarboxylate transporters (MCT1 and MCT4), and multidrug resistance (MDR) markers (MDR1 and MRP2) in 4 epithelial ovarian cancer (EOC) cell lines and primary tumors (n = 120) along with the matched metastatic l...

Alternative Titles

Full title

Co-expression of CD147/EMMPRIN with monocarboxylate transporters and multiple drug resistance proteins is associated with epithelial ovarian cancer progression

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_762470455

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_762470455

Other Identifiers

ISSN

0262-0898

E-ISSN

1573-7276

DOI

10.1007/s10585-010-9345-9

How to access this item